HT-KIT

N/A

Report date: 2025/04/08 11:49:09
NME

Base Information

Drug NameHT-KIT
Drug Alias NameHT-KIT mRNA Frame Shifting TherapeuticHT-KIT
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionStem cell growth factor receptor inhibitorsRNA interference
TargetsStem cell growth factor receptor
Therapy Area/IndicationsAnaphylaxisSarcomaMastocytosis, Systemic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesNorth Carolina State University
China Registration ClassN/A

Develop Information

Active CompaniesHoth Therapeutics IncWuxi Apptec Co Ltd
Inactive CompaniesN/A
Active IndicationsAnaphylaxisSarcomaMastocytosis, Systemic +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A